Category: Smith & Nephew
Smith & Nephew acquires the Brazilian distribution of its wound care products from Politec Saúde.
Smith & Nephew (FTSE:SN, NYSE:SNN) said it acquired the Brazilian distribution of its wound care products from Politec Saúde for an undisclosed amount.
Shareholders of Interlace Medical, which Hologic acquired in 2011, sue the women's health company for additional payouts of almost $15 million.
Hologic (NSDQ:HOLX) has already been through its fair share of legal action from its acquisition of Interlace Medical, which it acquired for $125 million in 2011.
The San Diego Chargers former team doctor, Dr. David Chao, spikes his bid to recover a $2.2 million malpractice loss from Smith & Nephew.
Company officials at Smith & Nephew discuss Q3 2013 earnings results. The company said it posted profits of $122 million, or 68¢ per share, on sales of $1.03 billion during the 3 months ended Sept. 28
Smith & Nephew shares tick down after the British medical device company reports a nearly 8% profit slip for the 3rd quarter and names a new board chairman.
Smith & Nephew (FTSE:SN, NYSE:SNN) tapped Roberto Quarta to be its new chairman and said its 3rd-quarter profits slid nearly 8%.
A bid to recover a $2.2 million malpractice loss by the San Diego Chargers team doctor, Dr. David Chao, from Smith & Nephew survives the medical device company's move to dismiss the case.
Sir John Buchanan, the chairman of Smith & Nephew, is reportedly getting ready to step down from the medical device company's board of directors.